digital health companies glp-1 management Business Report for Healthtech strategy The metabolic health revolution has
Description
Experts say high demand for the drugs could force officials to make a decision on insurance coverage.
This Review summarizes the available data about combination immunotherapies in T1DM, particularly addressing their clinical importance.
GLP-1 and GIP medications are key advancements in weight loss pharmacotherapy
Michelle Gourdine, Chief Medical Officer at CVS Caremark, explains how combining medication with health coaching and lifestyle support can help patients achieve more sustainable outcomes
No subscription
